Automated Endoscope Reprocessors 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Custom Ultrasonics 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2015-11-16
  • 사례 출판 날짜
    2015-11-16
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: custom ultrasonics automated endoscope reprocessors the united states food and drug administration (fda) has issued an alert concerning all automated endoscope reprocessors manufactured by custom ultrasonics. in accordance with a consent decree entered in january 2007 with custom ultrasonics, the fda ordered custom ultrasonics to recall all of its automated endoscope reprocessors (aers) from health care facilities due to the firm’s continued violations of the federal food, drug, and cosmetic act (fd&c act), applicable regulations, and the consent decree. fda is recommending that health care facilities currently using custom ultrasonics aers transition away from their use to alternative methods to reprocess flexible endoscopes as soon as possible. as part of the fda’s ongoing investigation into infections associated with reprocessed medical devices and aer devices used for cleaning and disinfection, the fda has been reviewing the validation test methods and performance data for all aer manufacturers. to date, custom ultrasonics has not demonstrated that its aers can adequately wash and disinfect endoscopes to mitigate the risk of patient infection. the fda’s most recent inspection of the custom ultrasonics’ facility in april 2015 documented continued violations. violations include the inability to validate that the aers can adequately wash and disinfect endoscopes to mitigate the risk of patient infection. the identified violations could result in an increased risk of infection transmission. the fda recommends that health care facilities currently using custom ultrasonics aers transition away from their use to alternative reprocessing methods as soon as possible. facilities are advised to: identify and transition to alternate methods to reprocess flexible endoscopes, such as manual high-level disinfection, liquid chemical sterilization, alternative aers, or other cleaning and sterilization methods according to the endoscope manufacturers’ reprocessing instructions. before transitioning to an alternative method, be sure that the endoscopes used are compatible with the alternative method by referring to the endoscope manufacturer’s reprocessing instructions. for details, please refer to the fda websites:http://www.Fda.Gov/medicaldevices/safety/alertsandnotices/ucm472462.Htmhttp://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm472686.Htm posted on 16 november 2015.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Custom Ultrasonics Automated Endoscope Reprocessors
  • Manufacturer

Manufacturer